1. Home
  2. HSDT vs PRSO Comparison

HSDT vs PRSO Comparison

Compare HSDT & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSDT
  • PRSO
  • Stock Information
  • Founded
  • HSDT 2014
  • PRSO 2008
  • Country
  • HSDT United States
  • PRSO United States
  • Employees
  • HSDT N/A
  • PRSO N/A
  • Industry
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PRSO Semiconductors
  • Sector
  • HSDT Health Care
  • PRSO Technology
  • Exchange
  • HSDT Nasdaq
  • PRSO Nasdaq
  • Market Cap
  • HSDT 2.9M
  • PRSO 3.3M
  • IPO Year
  • HSDT N/A
  • PRSO 2001
  • Fundamental
  • Price
  • HSDT $0.54
  • PRSO $0.94
  • Analyst Decision
  • HSDT Buy
  • PRSO Strong Buy
  • Analyst Count
  • HSDT 2
  • PRSO 2
  • Target Price
  • HSDT $24.00
  • PRSO $3.38
  • AVG Volume (30 Days)
  • HSDT 241.1K
  • PRSO 76.9K
  • Earning Date
  • HSDT 03-27-2025
  • PRSO 03-17-2025
  • Dividend Yield
  • HSDT N/A
  • PRSO N/A
  • EPS Growth
  • HSDT N/A
  • PRSO N/A
  • EPS
  • HSDT N/A
  • PRSO N/A
  • Revenue
  • HSDT $502,000.00
  • PRSO $12,728,000.00
  • Revenue This Year
  • HSDT N/A
  • PRSO $9.59
  • Revenue Next Year
  • HSDT $8.97
  • PRSO $1.63
  • P/E Ratio
  • HSDT N/A
  • PRSO N/A
  • Revenue Growth
  • HSDT N/A
  • PRSO N/A
  • 52 Week Low
  • HSDT $0.37
  • PRSO $0.73
  • 52 Week High
  • HSDT $7.19
  • PRSO $2.34
  • Technical
  • Relative Strength Index (RSI)
  • HSDT 43.07
  • PRSO 50.19
  • Support Level
  • HSDT $0.50
  • PRSO $0.82
  • Resistance Level
  • HSDT $0.60
  • PRSO $0.92
  • Average True Range (ATR)
  • HSDT 0.06
  • PRSO 0.07
  • MACD
  • HSDT -0.01
  • PRSO 0.02
  • Stochastic Oscillator
  • HSDT 15.87
  • PRSO 60.38

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

Share on Social Networks: